Showing posts with label
life sciences
.
Show all posts
Showing posts with label
life sciences
.
Show all posts
Thursday, June 20, 2024
Illumina's strong market position in the genomics and life sciences sectors, positive return on equity, recent insider buying and Ai applications signal confidence in its future
›
Illumina Inc. (NASDAQ: ILMN), has several positive indicators for the company's prospects going forward. Analyst Ratings and Price Targ...
1 comment:
›
Home
View web version
